PREGVAX

Plasmodium Vivax Infection in Pregnancy

 Coordinatore FUNDACIO PRIVADA CLINIC PER A LA RECERCA BIOMEDICA 

 Organization address address: CARRER ROSSELLO 149-153
city: BARCELONA
postcode: 8029

contact info
Titolo: Dr.
Nome: Mireia
Cognome: Piqueras
Email: send email
Telefono: +34 93 227 18 51
Fax: +93 227 18 50

 Nazionalità Coordinatore Spain [ES]
 Totale costo 3˙928˙460 €
 EC contributo 2˙999˙145 €
 Programma FP7-HEALTH
Specific Programme "Cooperation": Health
 Code Call FP7-HEALTH-2007-A
 Funding Scheme CP-FP
 Anno di inizio 2008
 Periodo (anno-mese-giorno) 2008-03-01   -   2012-08-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    FUNDACIO PRIVADA CLINIC PER A LA RECERCA BIOMEDICA

 Organization address address: CARRER ROSSELLO 149-153
city: BARCELONA
postcode: 8029

contact info
Titolo: Dr.
Nome: Mireia
Cognome: Piqueras
Email: send email
Telefono: +34 93 227 18 51
Fax: +93 227 18 50

ES (BARCELONA) coordinator 0.00
2    CENTRO INTERNACIONAL DE VACUNAS

 Organization address address: Carrera 35 4A-53
city: CALI
postcode: 25574

contact info
Titolo: Ms.
Nome: Ruth
Cognome: Abello Solis
Email: send email
Telefono: +57 2 5216231
Fax: +57 2 5560141

CO (CALI) participant 0.00
3    FUNDACAO DE MEDICINA TROPICAL DO AMAZONES

 Organization address address: Av. Pedro Teixeira 25
city: MANAUS
postcode: 69040-000

contact info
Titolo: Dr.
Nome: Silas
Cognome: Guedes
Email: send email
Telefono: +55 92 644 1602
Fax: +55 92 644 1620

BR (MANAUS) participant 0.00
4    FUNDACION DE LA UNIVERSIDAD DEL VALLE DE GUATEMALA

 Organization address address: 18 Calle Vista Hermosa III 15-79 zona 15 Guatemala
city: GUATEMALA
postcode: 1901

contact info
Titolo: Ms.
Nome: Maria Eugenia
Cognome: López
Email: send email
Telefono: +502 2364 0336
Fax: +502 2369 7479

GT (GUATEMALA) participant 0.00
5    INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY

 Organization address address: PADRICIANO 99
city: TRIESTE
postcode: 34149

contact info
Titolo: Ms.
Nome: Shubhalakshmi Hariharan
Cognome: Narayanan
Email: send email
Telefono: +91 11 26742356
Fax: +91 11 26742316

IT (TRIESTE) participant 0.00
6    ISTITUTO SUPERIORE DI SANITA

 Organization address address: Viale Regina Elena 299
city: ROMA
postcode: 161

contact info
Titolo: Ms.
Nome: Rosa Maria
Cognome: Martoccia
Email: send email
Telefono: +39 06 49902688
Fax: +39 06 49903007

IT (ROMA) participant 0.00
7    KAROLINSKA INSTITUTET

 Organization address address: Nobels Vag 5
city: STOCKHOLM
postcode: 17177

contact info
Titolo: Ms.
Nome: Christina
Cognome: Bergehed-Bonnevier
Email: send email
Telefono: +46 8 524 871 40
Fax: +46 8 33 97 44

SE (STOCKHOLM) participant 0.00
8    PAPUA NEW GUINEA INSTITUTE OF MEDICAL RESEARCH - PNGIMR

 Organization address address: CORNER OF LEIGH VIAL & HOMATE STREETS - GOROKA BASE HOSPITAL GROUNDS TOWN OF GOROKA IN THE EASTERN HIGHLANDS PROVINCE
city: GOROKA
postcode: 441

contact info
Titolo: Mr.
Nome: Samson
Cognome: Akunaii
Email: send email
Telefono: +675 732 2800
Fax: +675 732 1998

PG (GOROKA) participant 0.00
9    RAJASTHAN UNIVERSITY OF HEALTH SCIENCES JAIPUR

 Organization address address: TONK ROAD SECTOR 18 KUMBHA MACG
city: JAIPUR
postcode: 302003

contact info
Titolo: Dr.
Nome: Swati
Cognome: Kochar
Email: send email
Telefono: +91 151 2523454
Fax: +91 151 2201119

IN (JAIPUR) participant 0.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

facility    prevalence    infection    enrolled    women    falciparum    malaria    colombia    health       infections    immunological    countries    site    endemic    sub    pregnant    brazil    vivax    impact    guatemala    pregnancy   

 Obiettivo del progetto (Objective)

'Malaria in pregnancy has been recently prioritised by the EC 7th Framework Program. In response, we propose to carry out a cohort observational study in pregnant women in 5 P. vivax endemic countries, broadly representing most of the world's infections. The Indian and Papua New Guinean endemic sites are included because of their important contribution to the global burden of vivax malaria; PNG has a high prevalence of asymptomatic P. vivax infections resembling P. falciparum infection in sub-Saharan Africa, and India contributes to nearly 80% of malaria cases in Southeast Asia. In Latin America, 3 countries are selected, Guatemala, Colombia and Brazil. In Guatemala P vivax is responsible for almost all malaria cases, in Colombia and Brazil it co-exists in different proportions with falciparum. Pregnant women will be enrolled at each site during routine antenatal care visits (ANC) and followed-up at the health facility until delivery or end of pregnancy. P. vivax malaria parasitaemia will be assessed at enrolment, at every contact with the health facility and at delivery. In a sub-sample of women, peripheral blood will be taken for immunological/molecular studies, and placental samples will be collected. To assess with precision the prevalence of infection (estimated to be around 4% on average) and to obtain sufficient number of pregnant women with P vivax infection to determine the impact on birthweight, 2000 pregnant women per site will be enrolled. Due to the likely low prevalence of infection in pregnancy, the number of pregnant women with P. vivax per site will probably not be enough to assess specific impact for each site, thus a multicentric study design will be used. Immunological analysis will be performed to unveil whether there are pregnancy-specific immune responses. Phenotypic and genotypic analyses of parasites from the placenta should reveal their adhesive properties and whether the accumulation of infected erythrocytes unique parasite population.'

Altri progetti dello stesso programma (FP7-HEALTH)

IMPROVE (2014)

Improving Prostate Cancer Outcome with Vectored Vaccines

Read More  

EFACTS (2010)

European Friedreich's Ataxia Consortium for Translational Studies

Read More  

NATT (2008)

New Approaches to Target Tuberculosis

Read More